Your browser doesn't support javascript.
loading
[Research and development technology platform and research progress of universal influenza vaccine].
Deng, T; Zhang, J Y; Yang, X M.
Afiliação
  • Deng T; The 2nd Research Department of Viral Vaccine, Wuhan Institute of Biological Products, Wuhan Institute of Biological Products, Wuhan 430207, China National Engineering Technology Research Center for Combined Vaccines, Wuhan 430207, China.
  • Zhang JY; The 2nd Research Department of Viral Vaccine, Wuhan Institute of Biological Products, Wuhan Institute of Biological Products, Wuhan 430207, China National Engineering Technology Research Center for Combined Vaccines, Wuhan 430207, China.
  • Yang XM; National Engineering Technology Research Center for Combined Vaccines, Wuhan 430207, China China Biotechnology Co., Ltd, Beijing 100029, China.
Zhonghua Yu Fang Yi Xue Za Zhi ; 55(12): 1500-1506, 2021 Dec 06.
Article em Zh | MEDLINE | ID: mdl-34963251
Vaccination is the most effective measure to prevent influenza. However, due to the existence of antigen drift and/or antigen shift of influenza virus, the vaccine strains often do not match the epidemic strains, so that the protection provided by influenza vaccine is still limited. With the rapid development of new vaccine technology, a kind of influenza vaccine with extensive protection or universal has attracted great attention. It can effectively induce humoral and cellular immunity against the conserved epitopes of influenza virus, provide good protection against various types/subtypes of influenza virus, and has a rapid production platform, which is the ideal goal for the development of a new generation of universal influenza vaccine. This article reviews the latest research progress of influenza universal vaccine.
Assuntos

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 Base de dados: MEDLINE Assunto principal: Vacinas contra Influenza / Influenza Humana Limite: Humans Idioma: Zh Revista: Zhonghua Yu Fang Yi Xue Za Zhi Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 Base de dados: MEDLINE Assunto principal: Vacinas contra Influenza / Influenza Humana Limite: Humans Idioma: Zh Revista: Zhonghua Yu Fang Yi Xue Za Zhi Ano de publicação: 2021 Tipo de documento: Article